Major Shift In HIV Prevention Priorities Needed
The most common HIV prevention strategies-condom promotion, HIV testing, treatment of other sexually transmitted infections, vaccine and microbicide research, and abstinence-are having a limited impact on the predominantly heterosexual epidemics found in Africa.
|
Exhaustion Of HIV T Cells Caused By Exposure To Virus
The "exhaustion" of immune cells that target HIV appears to result from chronic exposure to the virus, specifically exposure to the particular protein segments targeted by the pathogen-killing HIV-specific CD8 T cells.
|
Expert Says UN HIV, AIDS Program Ineffective
The exclusive focus on HIV promoted by the Joint United Nations Programme on HIV/AIDS (UNAIDS) is damaging health systems and distorting health financing, and UNAIDS should be closed down immediately.
|
Antiretroviral Therapy Effects Vary Based On Race, Gender
Although the overall rate of adverse events among HIV-positive people initiating antiretroviral treatment does not differ significantly among different races and genders, there are significant differences for specific adverse events.
|
Findings Open New Front In Fight Against AIDS Virus
A research group has uncovered a new route for attacking the human immunodeficiency virus (HIV) that may offer a way to circumvent problems with drug resistance.
|
Schering-Plough Initiates Study With Vicriviroc In Treatment-Naive HIV-Infected Patients
Schering-Plough Corporation has initiated a Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only.
|
HIV Might Spread More Quickly Within Body Than Thought
Each rhesus monkey cell infected with the simian immunodeficiency virus, or SIV, produces at least 50,000 viruses over its life span, suggesting HIV spreads more rapidly than previously estimated.
|
HIV Drug May Double Heart Attack Risk
A widely used anti-HIV drug is found to increase risk for heart attack.
|
Monogram HIV Antibody Assay Is Key Vaccine Development Program
Maxygen is using Monogram's Neutralizing Antibody Assay in its HIV vaccine program to rapidly and accurately screen candidate immunogens produced by gene shuffling for their ability to induce antibodies that protect against a broad range of HIV variants.
|
Girls Bear Most Of The HIV Cases in NIgeria
An estimated 61% of new HIV cases in Nigeria occur among girls and women.
|
Increasing Access To Antiretroviral Drugs Would Drastically Cut AIDS Deaths In Africa
More that 1.2 million deaths could be prevented in South Africa over the next five years by accelerating efforts to provide access to antiretroviral therapy.
|
Trial Examines Efficacy Of Merck's Antiretroviral Raltegravir
Tucson Citizen examined a worldwide trial of Merck's antiretroviral drug raltegravir.
|
AIDS Vaccine Failure Pushes Researchers To New Direction
AIDS researchers are puzzled at the Summit on HIV Vaccine Research and Development discussing a new directions for AIDS vaccine, after two human trials of AIDS vaccine failed several months ago.
|
Genetic Variations Might Be Causing Mutations To HIV
Genetic variations that might help people newly diagnosed with HIV control their viral loads also could be causing a mutation in the virus that makes it less potent.
|
Researchers discover 'off switch' for HIV-infected cells
In a promising new finding that could help HIV treatment, researchers in the US have discovered how a genetic circuit in HIV controls whether the virus turns on or stays dormant.
|
HIV victims get effective tuberculosis screening test
The development of new IGRA3 tests for HIV victims is based on in vitro measurement of T-cells secretion of interferon- when challenged with antigens specific to Mycobacterium tuberculosis, the bacterium causing tuberculosis
|
Anti HIV Gel Trial Fails
A large study of an anti-HIV gel failed to protect study volunteers from being infected.
|
HIV Vaccine Research Fails Leaving Science Hopeless
Scientists have no hope that HIV may be found in nearest future.
|
Anti-Herpes Drug Does Not Reduce Risk Of HIV Infection
The anti-herpes drug acyclovir did not reduce the risk of acquiring sexually transmitted HIV.
|
Arrests, Trials of HIV-Positive Men In Egypt Fueling Stigma Against People Living With Disease
Recent arrests and trials of HIV-positive men in Egypt are endangering human rights and fueling discrimination against people living with the disease in the country.
|
INTELENCE Effective As Part Of HIV Combination Therapy
At 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented resistance to NNRTIs and PIs had an undetectable viral load with INTELENCE tablets.
|
Roche, Clinton Foundation To Deliver HIV Tests To African Infants
Roche and the Clinton Foundation HIV/AIDS Initiative have partnered in an effort to increase access to HIV testing among infants in 24 sub-Saharan African countries.
|
New HIV Cases In Sweden Increased
The number of new HIV cases recorded in Sweden in 2007 increased by 20%.
|
African Women Address HIV/AIDS-Related Abuse
Hundreds of African women discussed issues surrounding violence against women living with HIV/AIDS.
|
Examining Aging Among Long-Term HIV Survivors
Los Angeles Times examined issues surrounding aging among long-term HIV survivors in US.
|
Lack Of HIV/AIDS Awareness Widespread In Singapore
A lack of basic knowledge about HIV/AIDS is widespread in Singapore despite public awareness campaigns about the disease.
|
Bush budget 2009 a disaster for HIV/AIDS
The President's proposed budget for fiscal year 2009, if enacted, would spell disaster for the nation's health, and by extension, our national effort to respond to the HIV/AIDS epidemic in the United States.
|
Examining Immune Cells Where HIV Can Lie Dormant
Researchers have determined how HIV is able to lie dormant in certain immune system cells and prevent the cells from self-destructing.
|
Maharashtra Proposes Mandatory HIV Tests Before Marriage
India's Maharashtra state will pass a law requiring HIV tests before marriage.
|
Papua New Guinea Coalition To Implement Programs Against HIV/AIDS
Papua New Guinea Business Coalition Against HIV/AIDS plans to work with businesses in the country to implement the coalition's policy on HIV/AIDS in the workplace.
|
Number Of HIV-Positive People In Vietnam With Drug Access Increasing
The number of HIV-positive people in Vietnam with access to antiretroviral drugs increased in 2007.
|
UNAIDS To Provide HIV Prevention, Treatment Programs
UNAIDS aims to provide HIV prevention and treatment services to 80% of injection drug users in the Asia-Pacific region during the next two years.
|
Lobby Legislators To Increase HIV Prevention
Virginia volunteers lobbied state lawmakers to allocate additional funds for increased HIV prevention and education in the state.
|
Newly Approved HIV Drug Shows Great Promise
AIDS Institute is encouraged with FDA's approval of the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) in nearly a decade.
|
RNA-Interference Technology Unveils Potential New Targets For HIV Drugs
RNA-interference technology identified human proteins required for growth of the human immunodeficiency virus (HIV).
|
Program To Fight Virus Among HIV-Positive
A group of HIV-positive teachers in Kenya's Central province has formed a program aimed at educating teachers and students about HIV/AIDS.
|
Jamaican Initiative To Support HIV-Positive People
Jamaica's National Council on Drug Abuse to establish 10 clinics across the island that will support substance users, people living with HIV/AIDS.
|
Philippines Congress To Fight HIV/AIDS
Philippines Congress has allocated 750 million pesos, or about $18 million, in the 2008 national budget to help fight HIV/AIDS.
|
HIV/AIDS Advocates Calling For Increased Funding For PEPFAR
Some HIV/AIDS advocates are calling on Congress to allocate more money than President Bush has asked.
|
Report Provides Information On HIV Prevalence In US
Approximately half of 1 percent of US household population between the ages of 18 and 49 are living with HIV.
|
